Canada - engleză - Health Canada

aa pharma inc - methyldopa - tablet - 500mg - methyldopa 500mg - central alpha-agonists

Canada - engleză - Health Canada

pro doc limitee - methyldopa - tablet - 250mg - methyldopa 250mg - central alpha-agonists

Canada - engleză - Health Canada

pro doc limitee - methyldopa - tablet - 500mg - methyldopa 500mg - central alpha-agonists

Canada - engleză - Health Canada

pro doc limitee - methyldopa - tablet - 125mg - methyldopa 125mg - central alpha-agonists

Canada - engleză - Health Canada

laboratoires confab inc - methyldopa - tablet - 125mg - methyldopa 125mg - central alpha-agonists

Canada - engleză - Health Canada

laboratoires confab inc - methyldopa - tablet - 250mg - methyldopa 250mg - central alpha-agonists

Canada - engleză - Health Canada

laboratoires confab inc - methyldopa - tablet - 500mg - methyldopa 500mg - central alpha-agonists

Kenya - engleză - Pharmacy and Poisons Board

national pharmacy ltd p.o box 17843-00500 - methyldopa - tablet - 250mg - methyldopa (levorotatory)

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amiloride hydrochloride anhydrous 5 mg - amiloride hydrochloride and hydrochlorothiazide tablets are indicated in those patients with hypertension or with congestive heart failure who develop hypokalemia when thiazides or other kaliuretic diuretics are used alone, or in whom maintenance of normal serum potassium levels is considered to be clinically important, e.g., digitalized patients, or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hydrochloride and hydrochlorothiazide tablets may be used alone or as an adjunct to other antihypertensive drugs, such as methyldopa or beta blockers. since amiloride hydrochloride and hydrochlorothiazide enhances the action of these agents, dosage adjustments may be necessary to avoid an excessive fall in blood pressure and other unwanted side effects. this fixed combination drug is not indicated for the initial therapy of edema or hyper

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amiloride hydrochloride anhydrous 5 mg - amiloride hydrochloride and hydrochlorothiazide tablets are indicated in those patients with hypertension or with congestive heart failure who develop hypokalemia when thiazides or other kaliuretic diuretics are used alone, or in whom maintenance of normal serum potassium levels is considered to be clinically important, e.g., digitalized patients, or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hydrochloride and hydrochlorothiazide tablets may be used alone or as an adjunct to other antihypertensive drugs, such as methyldopa or beta blockers. since amiloride hydrochloride and hydrochlorothiazide enhances the action of these agents, dosage adjustments may be necessary to avoid an excessive fall in blood pressure and other unwanted side effects. the fixed combination drug is not indicated for the initial therapy of edema or hypert